Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo.
Gigliotti CL, Boggio E, Clemente N, Shivakumar Y, Toth E, Sblattero D, D'Amelio P, Isaia GC, Dianzani C, Yagi J, Rojo JM, Chiocchetti A, Boldorini R, Bosetti M, Dianzani U. Gigliotti CL, et al. Among authors: dianzani u, dianzani c. J Immunol. 2016 Nov 15;197(10):3905-3916. doi: 10.4049/jimmunol.1600424. Epub 2016 Oct 19. J Immunol. 2016. PMID: 27798154 Free article.
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
Boggio E, Gigliotti CL, Moia R, Scotta A, Crespi I, Boggione P, De Paoli L, Deambrogi C, Garzaro M, Vidali M, Chiocchetti A, Stoppa I, Rolla R, Dianzani C, Monge C, Clemente N, Gaidano G, Dianzani U. Boggio E, et al. Among authors: dianzani u, dianzani c. Br J Haematol. 2022 Mar;196(6):1369-1380. doi: 10.1111/bjh.17968. Epub 2021 Dec 26. Br J Haematol. 2022. PMID: 34954822
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.
Stoppa I, Gigliotti CL, Clemente N, Pantham D, Dianzani C, Monge C, Puricelli C, Rolla R, Sutti S, Renò F, Boldorini R, Boggio E, Dianzani U. Stoppa I, et al. Among authors: dianzani u, dianzani c. Int J Mol Sci. 2022 Jul 1;23(13):7363. doi: 10.3390/ijms23137363. Int J Mol Sci. 2022. PMID: 35806368 Free PMC article.
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF, Stoppa I, Aimaretti E, Monge C, Mastrocola R, Porchietto E, Einaudi G, Collotta D, Bertocchi I, Boggio E, Gigliotti CL, Clemente N, Aragno M, Fernandes D, Cifani C, Thiemermann C, Dianzani C, Dianzani U, Collino M. Alves GF, et al. Among authors: dianzani u, dianzani c. Front Immunol. 2022 Sep 2;13:992614. doi: 10.3389/fimmu.2022.992614. eCollection 2022. Front Immunol. 2022. PMID: 36119089 Free PMC article.
B7h triggering inhibits the migration of tumor cell lines.
Dianzani C, Minelli R, Gigliotti CL, Occhipinti S, Giovarelli M, Conti L, Boggio E, Shivakumar Y, Baldanzi G, Malacarne V, Orilieri E, Cappellano G, Fantozzi R, Sblattero D, Yagi J, Rojo JM, Chiocchetti A, Dianzani U. Dianzani C, et al. Among authors: dianzani u. J Immunol. 2014 May 15;192(10):4921-31. doi: 10.4049/jimmunol.1300587. Epub 2014 Apr 11. J Immunol. 2014. PMID: 24729612 Free article.
Osteopontin binds ICOSL promoting tumor metastasis.
Raineri D, Dianzani C, Cappellano G, Maione F, Baldanzi G, Iacobucci I, Clemente N, Baldone G, Boggio E, Gigliotti CL, Boldorini R, Rojo JM, Monti M, Birolo L, Dianzani U, Chiocchetti A. Raineri D, et al. Among authors: dianzani u, dianzani c. Commun Biol. 2020 Oct 26;3(1):615. doi: 10.1038/s42003-020-01333-1. Commun Biol. 2020. PMID: 33106594 Free PMC article.
244 results